Lundbeck Expands CNS Franchise with US$2 B Alder Acquisition

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 9 (Table of Contents)

Published: 19 Sep-2019

DOI: 10.3833/pdr.v2019.i9.2458     ISSN: 1756-7874

Section: Mergers & Acquisitions



As it faces pressure from upcoming patent expirations and generic competition, Lundbeck has agreed to acquire Alder BioPharmaceuticals to diversify its CNS franchise...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details